Enanta Pharmaceuticals (ENTA) Net Shares Issued and Repurchased (2013 - 2025)
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Net Shares Issued and Repurchased (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 10 | Enanta Pharmaceuticals | 405.22 Mn | 215.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.15 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 765,000.00 |
| Dec 31, 2022 | 618,000.00 |
| Sep 30, 2022 | 894,000.00 |
| Dec 31, 2021 | 607,000.00 |
| Sep 30, 2021 | 901,000.00 |
| Dec 31, 2020 | 619,000.00 |
| Sep 30, 2020 | 820,000.00 |
| Dec 31, 2019 | 577,000.00 |
| Sep 30, 2019 | 653,000.00 |
| Dec 31, 2018 | 484,000.00 |
| Sep 30, 2018 | 606,000.00 |
| Dec 31, 2017 | 466,000.00 |
| Sep 30, 2017 | 613,000.00 |
| Dec 31, 2016 | 484,519.00 |
| Sep 30, 2016 | 509,680.00 |